MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
MRTX
Delisted
MRTX was delisted on the 22nd of January, 2024.
200 hedge funds and large institutions have $5.53B invested in Mirati Therapeutics, Inc. Common Stock in 2020 Q2 according to their latest regulatory filings, with 46 funds opening new positions, 85 increasing their positions, 49 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
8% less call options, than puts
Call options by funds: $46.5M | Put options by funds: $50.5M
14% less funds holding in top 10
Funds holding in top 10: 7 → 6 (-1)
Holders
200
Holding in Top 10
6
Calls
$46.5M
Puts
$50.5M
Top Buyers
| 1 | +$53.8M | |
| 2 | +$37.2M | |
| 3 | +$29.4M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$23M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$21.3M |
Top Sellers
| 1 | -$80.2M | |
| 2 | -$62.6M | |
| 3 | -$53.6M | |
| 4 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$40M |
| 5 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$22.7M |